Health
Oxford-AstraZeneca COVID-19 Vaccine To Be Tested On Children For First Time – HuffPost
The new mid-stage trial will determine whether the coronavirus shot is effective on people between the ages of six and 17.
(Reuters) – The University of Oxford has launched a study to assess the safety and immune response of the COVID-19 vaccine it has developed with AstraZeneca Plc in children for the first time, it said on Saturday.
The new mid-stage trial will determine whether the vaccine is effective on people between the ages of 6 and 17, according to an emailed statement from the university.
Around 300 volunteers will be enrolled and first inoculations are expected this month, Oxford said.
The two-dose Oxford/AstraZeneca…
-
General19 hours agoCampers evacuated, residents on alert as Moreton Island bushfire intensifies
-
General17 hours agoHundreds attend justice march for Kaiden Morgan-Johnston in Morwell
-
Noosa News17 hours agoHow Roosters star Eliza Lopamaua found her way to NRLW
-
General15 hours agoMitch Marsh inspires Australia to three-wicket win over New Zealand in third T20I